# Harald Arnesen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/harald-arnesen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,182 |
| Field | Acute Myocardial Infarction Research |
| h-index | 71 |
| i10-index | 263 |
| Last Known Institution | Oslo University Hospital |
| OpenAlex ID | https://openalex.org/A5084461040 |
| ORCID iD | 0000-0002-0409-8792 |
| Works | 501 |

## Researcher papers

Showing 12 of 19.

- [Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial Infarction](https://scholariq.org/papers/intracoronary-injection-of-mononuclear-bone-marrow-cells-in-acute-myocardial/)
- [Warfarin, Aspirin, or Both after Myocardial Infarction](https://scholariq.org/papers/warfarin-aspirin-or-both-after-myocardial-infarction/)
- [The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction](https://scholariq.org/papers/the-effect-of-warfarin-on-mortality-and-reinfarction-after-myocardial-infarction/)
- [Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology](https://scholariq.org/papers/bleeding-in-acute-coronary-syndromes-and-percutaneous-coronary-interventions/)
- [Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)](https://scholariq.org/papers/parenteral-anticoagulants-in-heart-disease-current-status-and-perspectives/)
- [Vitamin K antagonists in heart disease: Current status and perspectives (Section III)](https://scholariq.org/papers/vitamin-k-antagonists-in-heart-disease-current-status-and-perspectives-section/)
- [Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction](https://scholariq.org/papers/effects-of-n-3-fatty-acid-supplements-in-elderly-patients-after-myocardial/)
- [Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting](https://scholariq.org/papers/management-of-antithrombotic-therapy-in-atrial-fibrillation-patients-presenting/)
- [New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes](https://scholariq.org/papers/new-oral-anticoagulants-in-atrial-fibrillation-and-acute-coronary-syndromes/)
- [Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)](https://scholariq.org/papers/prolonged-thromboprophylaxis-following-hip-replacement-surgery-results-of-a/)
- [Efficacy and Safety of Immediate Angioplasty Versus Ischemia-Guided Management After Thrombolysis in Acute Myocardial Infarction in Areas With Very Long Transfer Distances](https://scholariq.org/papers/efficacy-and-safety-of-immediate-angioplasty-versus-ischemia-guided-management/)
- [Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease](https://scholariq.org/papers/aspirin-non-responsiveness-as-measured-by-pfa-100-in-patients-with-coronary/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Fatty Acid Research and Health](https://scholariq.org/topics/fatty-acid-research-and-health/)

## Researcher university

- [Oslo University Hospital](https://scholariq.org/institutions/oslo-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.